Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Therapy
Recent findings in cancer therapy described
March 16th, 2006
Cancer therapy research advances have been reported from Italy and the United States. Study 1: Gefitinib with weekly epirubicin controls disease in patients with metastatic breast cancer. "Epidermal growth factor receptor (EGFR) is overexpressed in approximately 50% of invasive breast carcinomas and it is correlated with hormone resistance and poor prognosis. EGFR suppression by gefitinib, a quinazoline derivative that inhibits phosphorylation of the specific receptor, represents a novel therapeutic strategy," scientists in Italy report. "A dose-finding study was performed to evaluate the combination of gefitinib with weekly...
Source: Women's Health Weekly (2006-03-16)
|
